InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
38%
T+90 mean return
-0.6%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Pomeroy Claire, Director. Officer active across 4 companies, notably Haemonetics CORP. Aggregated, 12 disclosures have been recorded. Activity tracked since 25 January 2022. The latest transaction was disclosed on 12 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations12 total
13,839 shares0Common StockSEC:0000947871-25-000185:0
2,207 sharesCommon StockSEC:0001127602-24-021034:0
11,455 shares0Common StockSEC:0000947871-24-000105:0
2,226 sharesCommon StockSEC:0001127602-23-022205:0
6,979 shares0Common StockSEC:0001209191-23-008335:0
2,730 sharesCommon StockSEC:0001127602-22-020702:0
6,024 shares0Common StockSEC:0001209191-22-023273:0
820 shares0Common StockSEC:0001062993-22-001585:0
820 shares0Common StockSEC:0001062993-22-001585
3,077 sharesCommon StockSEC:0001127602-21-023397
3,077 sharesCommon StockSEC:0001127602-21-023397:0
1,267 sharesCommon StockSEC:0001543407-16-000096:0
12 of 12 declarations
About Pomeroy Claire
Claire Pomeroy is a Director at Haemonetics Corp and Becton Dickinson & Co. She brings her expertise in strategy and governance to the board. As a board member, Claire Pomeroy plays a crucial role in strategic decision-making and overseeing the performance of both companies. Her experience in the healthcare sector is a valuable asset for both organizations.
